Published in
Springer (part of Springer Nature), Breast Cancer Research and Treatment, 2(166), p. 447-457
DOI: 10.1007/s10549-017-4453-8
Links
Tools
HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
Journal article published in 2017 by
Yanjun Hou,
Hiroaki Nitta,
Lai Wei 
,
Peter M. Banks,
Bryce Portier,
Anil V. Parwani,
Zaibo Li
,
Peter M. Banks,
Bryce Portier,
Anil V. Parwani,
Zaibo Li
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 